FDA Inspection 603706 — Versiti Blood Health, Inc

Versiti Blood Health, Inc — FEI 1873403

The FDA completed an inspection of Versiti Blood Health, Inc on June 18, 2009 in Indianapolis, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 18, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Indianapolis, IN (United States)